Evidence map›Paper›PMID 38400151›Full record

ArticleVaccines2024

Status of Routine Immunization Coverage in the World Health Organization African Region Three Years into the COVID-19 Pandemic.

Franck Mboussou, Sarah Kada, Maria Carolina Danovaro-Holliday, Bridget Farham, Marta Gacic-Dobo, Jessica C Shearer, Ado Bwaka, Adidja Amani, Roland Ngom, Yolande Vuo-Masembe and 2 more

Abstract read
In one paragraph

Article in Vaccines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Overcoming Vaccine Inequities and Research Gaps in Africa: Challenges and Opportunities Identified During the COVID-19 Pandemic.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Franck MboussouWorld Health Organization, Regional Office for Africa, Brazzaville P.O. Box 06, Congo.ORCID 0000-0002-9062-5084
Sarah KadaMomentum, JSI, Arlington, VA 22202, USA.ORCID 0000-0002-0021-0492
Maria Carolina Danovaro-HollidayWorld Health Organization Headquarters, Avenue Appia 20, 1211 Geneva, Switzerland.ORCID 0000-0001-7324-9198
Bridget FarhamWorld Health Organization, Regional Office for Africa, Brazzaville P.O. Box 06, Congo.ORCID 0000-0001-5463-0858
Marta Gacic-DoboWorld Health Organization Headquarters, Avenue Appia 20, 1211 Geneva, Switzerland.
Jessica C ShearerPATH, 455 Massachusetts Avenue NW, Washington, DC 20001, USA.ORCID 0000-0003-1025-5739
Ado BwakaWorld Health Organization, Regional Office for Africa, Brazzaville P.O. Box 06, Congo.
Adidja AmaniWorld Health Organization, Regional Office for Africa, Brazzaville P.O. Box 06, Congo.ORCID 0000-0002-4917-3995
Roland NgomWorld Health Organization, Regional Office for Africa, Brazzaville P.O. Box 06, Congo.
Yolande Vuo-MasembeWorld Health Organization, Regional Office for Africa, Brazzaville P.O. Box 06, Congo.
Charles Shey WiysongeWorld Health Organization, Regional Office for Africa, Brazzaville P.O. Box 06, Congo.ORCID 0000-0002-1273-4779
Benido ImpoumaWorld Health Organization, Regional Office for Africa, Brazzaville P.O. Box 06, Congo.

Funding

World Health Organization 001
6 · The paper itself

Abstract

Data from the WHO and UNICEF Estimates of National Immunization Coverage (WUENIC) 2022 revision were analyzed to assess the status of routine immunization in the WHO African Region disrupted by the COVID-19 pandemic. In 2022, coverage for the first and third doses of the diphtheria-tetanus-pertussis-containing vaccine (DTP1 and DTP3, respectively) and the first dose of the measles-containing vaccine (MCV1) in the region was estimated at 80%, 72% and 69%, respectively (all below the 2019 level). Only 13 of the 47 countries (28%) achieved the global target coverage of 90% or above with DTP3 in 2022. From 2019 to 2022, 28.7 million zero-dose children were recorded (19.0% of the target population). Ten countries in the region accounted for 80.3% of all zero-dose children, including the four most populated countries. Reported administrative coverage greater than WUENIC-reported coverage was found in 19 countries, highlighting routine immunization data quality issues. The WHO African Region has not yet recovered from COVID-19 disruptions to routine immunization. It is critical for governments to ensure that processes are in place to prioritize investments for restoring immunization services, catching up on the vaccination of zero-dose and under-vaccinated children and improving data quality.

Indexed as

African Regioncatch-upCOVID-19routine immunizationvaccination coverageWUENICzero-dose

Identifiers

PMID38400151
PMCPMC10891650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.